Goldman Sachs’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $8.6M | Buy |
|
|||||
|
2025
Q3 | $1.59M | Buy |
|
|||||
|
2025
Q2 | $178K | Sell |
|
|||||
|
2025
Q1 | $417K | Sell |
|
|||||
|
2024
Q4 | $769K | Buy |
|
|||||
|
2024
Q3 | $799K | Buy |
|
|||||
|
2024
Q2 | $1.14M | Buy |
|
|||||
|
2024
Q1 | $1.67M | Sell |
|
|||||
|
2023
Q4 | $4.88M | Buy |
|
|||||
|
2023
Q3 | $2.96M | Sell |
|
|||||
|
2023
Q2 | $3.51M | Buy |
|
|||||
|
2023
Q1 | $3.19M | Sell |
|
|||||
|
2022
Q4 | $3.92M | Buy |
|
|||||
|
2022
Q3 | $3.99M | Buy |
|
|||||
|
2022
Q2 | $511K | Sell |
|
|||||
|
2022
Q1 | $1.11M | Buy |
|
|||||
|
2021
Q4 | $1.33M | Buy |
|
|||||
|
2021
Q3 | $980K | Sell |
|
|||||
|
2021
Q2 | $2.57M | Buy |
|
|||||
|
2021
Q1 | $227K | Sell |
|
|||||
|
2020
Q4 | $326K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.56M | Buy |
|